FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes.
FGFR3 mutations have recently been identified in several benign epidermal skin lesions such as seborrheic keratosis, epidermal nevus and solar lentigo. The functional consequences of these mutations in human skin are as yet unknown. In this study we analyzed the functional effects of the most common FGFR3 mutation in benign skin tumors, the R248C FGFR3 hotspot mutation, in human HaCaT keratinocytes. The cells were stably transduced with either the R248C or wildtype FGFR3 IIIb cDNA using a retroviral vector system. FGFR3 mutant and wildtype cells showed similar growth rates at subconfluence. However, at confluence FGFR3 mutant keratinocytes revealed a significantly higher cell number than wildtype cells. Furthermore, FGFR3 mutant cells showed significantly lower levels of apoptosis and decreased attachment to fibronectin compared with FGFR3 wildtype cells. Expression of mutant FGFR3 did not alter migration and senescence. Microarray analysis revealed only a few differentially expressed genes between FGFR3 mutant and wildtype keratinocytes. Enhanced phosphorylation of ERK1/2 was observed in confluent R248C mutant HaCaT cells compared with wildtype keratinocytes. Our results suggest that an increased cell number at confluence along with a decreased apoptosis may contribute to the development of acanthotic tumors in FGFR3 mutant skin in vivo.
Hafner
Christian
C
Department of Dermatology, University of Regensburg, Regensburg, Germany. christian.hafner@klinik.uni-regensburg.de
Di Martino
Erica
E
Pitt
Eva
E
Stempfl
Thomas
T
Tomlinson
Darren
D
Hartmann
Arndt
A
Landthaler
Michael
M
Knowles
Margaret
M
Vogt
Thomas
T
D017209:Apoptosis / Q000235:genetics*; D002448:Cell Adhesion; D049109:Cell Proliferation; D006801:Humans; D015603:Keratinocytes / Q000378:metabolism*; D009154:Mutation; D010766:Phosphorylation; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics* / Q000378:metabolism
D051498:Receptor, Fibroblast Growth Factor, Type 3